Cyclomicin plyus
Cyclomicin plyus Uses, Dosage, Side Effects, Food Interaction and all others data.
Antibiotic substance produced by Streptomyces garyphalus.
Cycloserine, a broad-spectrum antibiotic, may be bactericidal or bacteriostatic, depending on its concentration at the site of infection and the susceptibility of the organism. Cycloserine works by blocking the formation of these peptidoglycans. By doing this the walls of the bacteria become weak and it results in the death of the bacteria
Trade Name | Cyclomicin plyus |
Generic | Cycloserine + Pyridoxine Hydrochloride |
Type | |
Therapeutic Class | |
Manufacturer | |
Available Country | Russia |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Cycloserine is a broad-spectrum antibiotic used in the treatment of tuberculosis and certain urinary tract infections (UTI).
Used in combination with up to 5 other drugs as a treatment for Mycobacterium avium complex (MAC) and is also used to treat tuberculosis (TB).
Cyclomicin plyus is also used to associated treatment for these conditions: Refractory Tuberculosis, Refractory Urinary Tract Infection
How Cyclomicin plyus works
Cycloserine is an analog of the amino acid D-alanine. It interferes with an early step in bacterial cell wall synthesis in the cytoplasm by competitive inhibition of two enzymes, L-alanine racemase, which forms D-alanine from L-alanine, and D-alanylalanine synthetase, which incorporates D-alanine into the pentapeptide necessary for peptidoglycan formation and bacterial cell wall synthesis.
Toxicity
Oral LD50 in mouse is 5290 mg/kg, and in rat is over 5000 mg/kg. Symptoms of a cycloserine overdose include drowsiness, confusion, headache, dizziness, irritability, numbness and tingling, difficulty speaking, paralysis, abnormal behavior, seizures, and unconsciousness.
Elimination Route
Rapidly and almost completely absorbed (70 to 90%) from the gastrointestinal tract following oral administration.
Half Life
Half-life in patients with normal renal function is 10 hours, and is prolonged in patients with impaired renal function.
Innovators Monograph
You find simplified version here Cyclomicin plyus